SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Exide: Overbought or bargain?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Renee Scherb who wrote ()3/5/1997 7:01:00 PM
From: mervin standifer   of 125
 
HI RENEE I STILL OWN MY EXIDE I THINK IT WILL GO TO 30 BY JUNE.SAME TIME IT DID IN 96. WHEN IT DOES I WILL SELL.

CHECK OUT A STOCK CALLED BZET. BIOFIELD DEVELOPED A BREAST CANCER DIAGNOSTIC SYSTEM,BUT THE FDA DISAPROVED IT,BUT MAY RECONSIDER.IF THEY DO THIS STOCK WILL JUMP UP QUICK.A BIG RISK BUT COULD PAY OFF BIG.I CAN'T BELIVE A COMPANY WOULD DEVELOPE SOMETHING WITHOUT KNOWING THAT THE FDA WOULD OR WOULD NOT APROVED IT,[ DO YOU SMELL POLITICS]ANY OTHER COMENTS OUT THERE, ABOUT THIS.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News